Buprenorphine And Naloxone Tablet
Product Images NDC 0904-7010

5 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 0904-7010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine-chem-structure.jpg (Image 02)

Buprenorphine-chem-structure.jpg (Image 02)
Chemical structure of buprenorphine hydrochloride, depicting its molecular framework with aromatic rings, hydroxyl groups, and a cyclopropylmethyl group, including the associated hydrochloride (HCl) moiety.*
FDA Label Image

Naloxone-chem-structure.jpg (Image 04)

Naloxone-chem-structure.jpg (Image 04)
Chemical structure of buprenorphine hydrochloride dihydrate, showing the molecular arrangement typical for the active ingredient in BUPRENORPHINE AND NALOXONE tablets.*
FDA Label Image

Bupr-naloxone-ifu-mouth-image (Image 03)

Bupr-naloxone-ifu-mouth-image (Image 03)
An instructional illustration showing a hand placing a sublingual tablet under the tongue inside an open mouth. The image demonstrates the method of administration for a sublingual medication tablet.*
FDA Label Image

2mg/0.5mg Carton Label (02e15812 2216 4c4d 9b98 Dc876b7672bc 01)

2mg/0.5mg Carton Label (02e15812 2216 4c4d 9b98 Dc876b7672bc 01)
Label for Major Pharmaceuticals Buprenorphine and Naloxone Sublingual Tablets USP, 2 mg/0.5 mg strength. The label indicates unit dose packaging of 50 tablets, with warnings for pharmacists to dispense with a medication guide and emergency care instructions for accidental ingestion by children. It includes storage instructions and packaging details, including the NDC 0904-7009-06 and distributor information for Major Pharmaceuticals in Indianapolis, IN.*
FDA Label Image

8mg/2mg Carton Label (02e15812 2216 4c4d 9b98 Dc876b7672bc 00)

8mg/2mg Carton Label (02e15812 2216 4c4d 9b98 Dc876b7672bc 00)
Label for Major Pharmaceuticals Buprenorphine and Naloxone Sublingual Tablets, USP, strength 8 mg/2 mg. The unit dose packaging contains 50 tablets (5 x 10) and includes warnings for pharmacists and caregivers. The label provides dosage details, storage instructions at 20° to 25°C, and notes that the package is not child resistant and for institutional use only. Distributor information including NDC 0904-7010-06 is shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.